What's Happening?
Research from UCLA suggests that creatine, commonly used as a supplement by athletes, may enhance the immune system's ability to fight cancer. The study found that creatine boosts the activity of dendritic cells, which are crucial in activating T cells to destroy
cancer. Experiments in mice and human cells showed that creatine supplementation improved the function of these immune cells, potentially making cancer immunotherapy more effective. The findings indicate that creatine could support the immune response required for successful cancer treatment.
Why It's Important?
This discovery could have significant implications for cancer treatment, particularly in improving the effectiveness of immunotherapies that currently benefit only a subset of patients. By enhancing the function of dendritic cells, creatine may help more patients respond positively to these therapies. This research highlights the potential of creatine as a supplement to support cancer treatment, offering a new avenue for improving patient outcomes. However, further clinical trials are needed to confirm these benefits in humans.
